Deinove appoints business development director

Michael Krel will form industrial alliances with leading chemicals companies

Deinove, a French specialist in Deinococcus bacteria for biofuels, green chemistry and antibiotics, has appointed Michael Krel to the newly created post of executive vice president, business development.

Krel was previously business development manager at Metabolic Explorer, a green chemistry company specialising in the development of fermentation processes for commodity chemicals.

Deinove chief executive Jacques Biton said Krel’s main role will be to form collaborations and licensing deals with biofuels and chemicals companies worldwide.

You may also like

Pharmaceutical
OGT begins full IVDR transition for CytoCell FISH probe portfolio

OGT begins full IVDR transition for CytoCell FISH probe portfolio

OGT has launched two IVDR-certified prenatal FISH probe kits as it begins transitioning its full CytoCell portfolio ahead of the EU’s 2028 Class C deadline
Pharmaceutical
CellCarta adds Tempus to companion diagnostic commercialisation network

CellCarta adds Tempus to companion diagnostic commercialisation network

CellCarta has partnered with Tempus to expand its CDx Commercialization Lab Network, giving biopharma sponsors a route from companion diagnostic development and regulatory approval to commercial testing in US oncology practice
Manufacturing
Edwards cryogenic portfolio now available globally

Edwards cryogenic portfolio now available globally

Bringing cryogenic cooling and vacuum technologies together in one integrated portfolio for customers worldwide
Manufacturing
SCHOTT Pharma launches EVERIC lyo & amber vials for light-sensitive ADCs

SCHOTT Pharma launches EVERIC lyo & amber vials for light-sensitive ADCs

Featuring the well-known EVERIC® lyo coating, EVERIC® lyo & amber is designed for lyophilised, light-sensitive antibody-drug-conjugates (ADCs). It offers reliable light protection at the primary packaging level, already during the fill-and-finish process. EVERIC amber is the first specialty vial for highly light-sensitive medications that simultaneously meets regulatory light transmission requirements in the EU, the U.S., and Japan
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing
Portable gas detection in the pharmaceutical sector

Portable gas detection in the pharmaceutical sector

Gas safety is a critical consideration in the pharmaceutical sector. Hazardous gases and airborne contaminants are common by-products of manufacturing processes … and employers must control worker exposure in accordance with relevant legislation and industry standards
Manufacturing
New legal duties for QPs in decentralised manufacturing

New legal duties for QPs in decentralised manufacturing

In this clip, Dr. Peter Gough explains that QPs will be responsible for supervising decentralised activities, conducting regular audits, carrying out periodic on-site visits, confirming GMP compliance to regulatory authorities and notifying changes that may affect quality or safety
Manufacturing
FDA escalates action against Dabur India over systemic data-integrity and cGMP failures

FDA escalates action against Dabur India over systemic data-integrity and cGMP failures

The US FDA has issued a warning letter to Dabur India following an inspection that identified falsified records, missing laboratory data, inadequate cleaning and process validation and weaknesses in quality-unit oversight, saying the company's response failed to address the systemic nature of the deficiencies
Subscribe now